Creative Medical Technology Holdings, Inc. Accounts Payable
Creative Medical Technology Holdings, Inc. (CELZ) had Accounts Payable of $684.40 thousand as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-08-07
- 2026-06-30: Accounts Payable, Current $684.40K.
- 2026-03-31: Accounts Payable, Current $293.45K.
- 2025-12-31: Accounts Payable, Current $270.69K.
- 2025-09-30: Accounts Payable, Current $247.16K.
| Period end | Accounts Payable, Current | Accounts Payable, Current as first filed |
|---|---|---|
| 2026-06-30 | $684.40K 10-Q · filed 2026-08-07 | |
| 2026-03-31 | $293.45K 10-Q · filed 2026-05-08 | |
| 2025-12-31 | $270.69K 10-Q · filed 2026-08-07 | |
| 2025-09-30 | $247.16K 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $263.45K 10-Q · filed 2025-08-08 | |
| 2025-03-31 | $272.19K 10-Q · filed 2025-05-09 | |
| 2024-12-31 | $273.53K 10-K · filed 2026-03-20 | |
| 2024-09-30 | $273.79K 10-Q · filed 2024-11-08 | |
| 2024-06-30 | $322.16K 10-Q · filed 2024-08-09 | |
| 2024-03-31 | $336.85K 10-Q · filed 2024-05-10 | |
| 2023-12-31 | $317.28K 10-K · filed 2025-03-14 | |
| 2023-09-30 | $367.05K 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $344.41K 10-Q · filed 2023-08-11 | |
| 2023-03-31 | $353.42K 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $3.27M 10-K · filed 2024-03-22 | |
| 2022-09-30 | $327.84K 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $310.68K 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $335.68K 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $761.86K 10-K · filed 2023-03-31 | |
| 2021-09-30 | $454.52K 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $365.04K 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $356.00K 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $350.90K 10-K · filed 2022-03-30 | |
| 2020-09-30 | $344.45K 10-Q · filed 2020-11-13 | |
| 2020-06-30 | $380.61K 10-Q · filed 2020-08-14 | |
| 2020-03-31 | $386.56K 10-Q · filed 2020-05-15 | |
| 2019-12-31 | $320.79K 10-K · filed 2021-03-17 | |
| 2019-09-30 | $323.80K 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $320.44K 10-Q · filed 2019-08-13 | |
| 2019-03-31 | $342.80K 10-Q · filed 2019-05-20 | |
| 2018-12-31 | $331.84K 10-K · filed 2020-04-06 | |
| 2018-09-30 | $242.84K 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $272.83K 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $233.43K 10-Q · filed 2018-08-03 | |
| 2017-12-31 | $237.57K 10-K · filed 2019-04-01 | |
| 2017-09-30 | $157.10K 10-Q · filed 2017-11-13 | |
| 2017-06-30 | $53.20K 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $96.88K 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $66.39K 10-K · filed 2018-03-29 | |
| 2016-09-30 | $44.85K 10-Q · filed 2016-11-10 | |
| 2016-06-30 | $25.60K 10-Q · filed 2016-08-19 | |
| 2016-03-31 | $19.60K 10-Q · filed 2016-05-13 | |
| 2015-12-31 | $0.00 10-K · filed 2017-02-13 | $17.08K 10-K · filed 2016-04-14 |
| 2015-09-30 | $12.66K 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $11.33K 10-Q · filed 2015-08-13 | |
| 2015-03-31 | $12.51K 10-Q · filed 2015-05-08 | |
| 2014-12-31 | $10.19K 10-K · filed 2016-04-14 | |
| 2014-09-30 | $11.32K 10-Q · filed 2014-11-12 | |
| 2014-06-30 | $10.42K 10-Q · filed 2014-08-08 | |
| 2014-03-31 | $12.04K 10-Q · filed 2014-05-13 | |
| 2013-12-31 | $8.08K 10-K · filed 2015-02-27 | |
| 2013-09-30 | $8.10K 10-Q · filed 2013-11-13 | |
| 2013-06-30 | $6.71K 10-Q · filed 2013-08-07 | |
| 2013-03-31 | $9.79K 10-Q · filed 2013-05-07 | |
| 2012-12-31 | $9.98K 10-K · filed 2014-03-17 | |
| 2012-09-30 | $8.30K 10-Q · filed 2012-11-07 | |
| 2012-06-30 | $7.80K 10-Q · filed 2012-08-09 | |
| 2012-03-31 | $7.71K 10-Q · filed 2012-05-11 | |
| 2011-12-31 | $7.87K 10-K · filed 2013-03-15 | |
| 2011-09-30 | $3.35K 10-Q · filed 2011-10-31 | |
| 2010-12-31 | $0.00 10-K · filed 2012-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |